The evolution of prescription drug monitoring programs

Pharmacoepidemiology and Drug Safety

Volumn 25, Issue 7, 2016, Pages 852-853

  Ashburn, Michael A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

opioid; pharmacoepidemiology; prescription drug monitoring program; substance use disorder

Indexed keywords

OPIATE; PRESCRIPTION DRUG;

DRUG MISUSE; DRUG MONITORING; HIGH RISK BEHAVIOR; HUMAN; NOTE; OPIATE ADDICTION; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; SUBSTANCE USE;

EID: 84977489717     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.4036     Document Type: Note

References (8)

1. Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in drug and opioid overdose deaths — United States, 2000–2014. MMWR Morb Mortal Wkly Rep 2016; 64(50-51): 1378–1382.
2. Manasco A, Griggs C, Leeds R, et al. Characteristics of state prescription drug monitoring programs: a state-by-state survey. Pharmacoepidemiol Drug Saf 2016; 25: 847–851.
3. Clark T, Eadie J, Knue P, Kreiner P, Strickler G. Prescription drug monitoring programs: an assessment of the evidence for best practices. The Pew Charitable Trusts; September 20, 2012.
4. Greenwood-Ericksen MB, Poon SJ, Nelson LS, Weiner SG, Schuur JD. Best practices for prescription drug monitoring programs in the emergency department setting: results of an expert panel. Ann Emerg Med 2015; doi: 10.1016/j.annemergmed.
5. Delcher C, Wagenaar AC, Goldberger BA, Cook RL, Maldonado-Molina MM. Abrupt decline in oxycodone-caused mortality after implementation of Florida's Prescription Drug Monitoring Program. Drug Alcohol Depend 2015; 150: 63–68.
6. Rutkow L, Chang HY, Daubresse M, Webster DW, Stuart EA, Alexander GC. Effect of Florida's Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use. JAMA Intern Med 2015; 175(10): 1642–1649.
7. Rasubala L, Pernapati L, Velasquez X, Burk J, Ren YF. Impact of a mandatory prescription drug monitoring program on prescription of opioid analgesics by dentists. PLoS One 2015; 10(8:e0135957).
8. Ringwalt C, Schiro S, Shanahan M, et al. The use of a prescription drug monitoring program to develop algorithms to identify providers with unusual prescribing practices for controlled substances. J Prim Prev 2015; 36(5): 287–299.